1
Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL)
Condition(s):Primary Mediastinal Large B-cell LymphomaLast Updated:April 1, 2021Recruiting
Circulating Tumor DNA: 781 Clinical Trials, Page 1 of 79
Hide Studies Not Open or Pending
2
Surgery Impact on Circulating Tumor DNA in Pancreatic Cancer
Condition(s):Resectable Pancreatic CancerLast Updated:January 4, 2023Completed
3
Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA
Condition(s):Hepatocellular CarcinomaLast Updated:May 20, 2022Not yet recruiting
4
Detection of Plasma Circulating Tumor DNA in Gastric Cancer
Condition(s):Circulating Tumor DNA (ctDNA); Gastric CancerLast Updated:April 28, 2022Recruiting
5
Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer
Condition(s):Locally Advanced Rectal Carcinoma; Circulating Tumor DNALast Updated:November 1, 2022Recruiting
6
Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer
Condition(s):Esophageal Cancer; Gastric CancerLast Updated:October 6, 2020Recruiting
7
Detection of Circulating Tumor DNA in p16- Locally Advanced Head Neck Squamous Cell Carcinoma
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:July 30, 2020Unknown status
8
Circulating Tumor DNA in Soft Tissue Sarcoma
Condition(s):Soft Tissue SarcomaLast Updated:January 10, 2023Recruiting
9
CIrculating Tumour DNA in Lung Cancer (CITaDeL): Optimizing Sensitivity and Clinical Utility
Condition(s):Lung Neoplasms; Lung Cancer; Neoplasm of Lung; Non Small Cell Lung CancerLast Updated:February 18, 2021Completed
10
Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer
Condition(s):Gastric Cancer; Circulating Tumor DNA (ctDNA)Last Updated:August 24, 2022Not yet recruiting